News
NEWS
LaVoieHealthScience Announces Appointment of Nick Hennen as Head of Media, Boston, Building Out Media Training for Staff and Clients
BOSTON & NEW YORK, Wednesday, November 9, 2022–LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today...
LaVoieHealthScience Bolsters Commercial Strategic Communications Expertise with the Hiring of Deborah Plumstead as Vice President
BOSTON & NEW YORK, August 16, 2022–LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced...
LaVoieHealthScience Announces Continuance of U.S. Service Marks for LHS Immersion® and The LHS Fifteen-Slide Presentation®
Proprietary Message & Positioning Platform Defines Narrative for Health & Science Innovators USPTO recognizes continued use of proprietary professional services, grants exclusive...
LaVoieHealthScience Announces Appointment of Gemma Bakx as Senior Vice President of Investor Relations and Financial Communications
Further Strengthens IR Leadership Team and Supports Integrated Strategic Communications Capabilities and Continued Business Growth...
LaVoie Health Science Included in Fast 50 2021 – The fastest-growing private companies in Mass.
LaVoie Health Science was recently included in the Boston Business Journals Fast 50 2021 which is a list of the fastest-growing private companies in Mass. Read the article HERE.
Donna L. LaVoie, President, CEO, and Founder of LaVoieHealthScience Interviewed by Global Business Reports
Donna LaVoie was recently interviewed by Global Business Reports. Read the interview HERE.
LaVoieHealthScience Builds on 2020 Momentum with an Updated Team Roster to Meet Client Growth in 2021
BOSTON & NEW YORK - January 7, 2021 (BUSINESS WIRE)--LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science...
LaVoieHealthScience Names James (Jim) Heins as Senior Vice President and Managing Director of its New York Practice
LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced the appointment of James (Jim) Heins as Senior Vice President and Managing Director of its New York practice, expanding the agency’s senior leadership team to seven members.
Donna L. LaVoie, President, CEO, and Founder of LaVoieHealthScience, Named to PharmaVOICE 100
BOSTON AND NEW YORK - AUGUST 03, 2020 LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today...
LaVoieHealthScience Forms Strategic Alliance with Bioscience Valuation BSV GmbH
BOSTON/NEW YORK/GRAINAU, GERMANY – June 22, 2020 — LaVoieHealthScience (“LHS”) and Bioscience Valuation BSV GmbH (“BSV”) today announced a strategic alliance between the two firms. The alliance...
COVID-19 Thought Leadership Lessons
COVID-19: Four Challenges for Issue Management Teams
pharmexec.com | 4/16/2020 | News
Donna L. LaVoie discusses four key industry areas that will experience downstream pressures in the wake of the COVID-19 crisis.
JTC and LaVoieHealthScience team up to offer a Virtual Investor Conference during global pandemic
proactiveinvestors.com | 4/17/2020 | News
JTC CEO Jenene Thomas and LaVoieHealthScience CEO Donna LaVoie tell Proactive the public relations firms are teaming up together to offer a Virtual Investor Conference during the global pandemic.
Managing a pharma company during three crises: lessons learned for Covid-19
statnews.com | 4/20/2020 | Featured Client News
When I started working in the biopharma industry 20 or so years ago, I didn’t think I would need to become an expert in crisis management. Yet during the past decade, I have found myself leading the corporate response to three very different existential crises in three different regions.
Time to Think Hard About Having a Crisis/Issues Management Plan
bio.org | 4/23/2020 | News
The current COVID-19 pandemic has emphasized the need for a crisis/issues management plan more than ever.